Ag. Macdonald et al., BIOCHEMICAL MARKERS OF BONE TURNOVER IN SERONEGATIVE SPONDYLARTHROPATHY - RELATIONSHIP TO DISEASE-ACTIVITY, British journal of rheumatology, 36(1), 1997, pp. 50-53
To investigate bone turnover in patients with seronegative spondylarth
ropathy, a bone formation marker, type 1 procollagen carboxy-terminal
propeptide (P1CP), and resorption markers, the pyridinium cross-links
of collagen [urinary free (f) PYR and DPYR], were measured. The median
f-PYR, f-DPYR and P1CP (+/- interquartile range) were 15.8 (6.00) nmo
l/mmol creatinine, 3.8 (2.2) nmol/mmol creatinine and 101.5 (38) mu g/
l, respectively. There was a positive correlation between resorption m
arkers and acute-phase reactants such as C-reactive protein (r = 0.4 f
or PYR, r = 0.42 for DPYR, P < 0.05), and a negative correlation obser
ved between P1CP and the erythrocyte sedimentation rate (r = -0.64, P
< 0.05). In the subgroup of patients with an elevated CRP concentratio
n, the concentration of PYR and DPYR was significantly increased (f-PY
R 25.7 vs 15.8 and f-DPYR 6.6 vs 3.8, P < 0.01 for f-PYR, P < 0.05 for
f-DPYR). This study suggests than an elevation in acute-phase respons
e in patients with seronegative spondylarthropathy is associated with
increased concentration of bone resorption markers with a tendency for
reduction in bone formation markers. This may represent uncoupling of
bone formation and resorption, leading to bone loss in such patients.